If you or someone you love has Von Willebrand Disease, there's something new on the horizon. A company called Hemab Therapeutics is studying a medicine called HMB-002, a simple shot given under the skin that's designed to help your body hold onto more of the von willebrand factor it needs.
Join Tara O'Meara and Henry Mead from Hemab Therapeutics as they explain how HMB-002 works, what the VELORA studies involve, and how you or a family member might be able to take part.
No contact or identifiable medical information will be provided to Industry or other organizations we partner with. We do not sell your information, it remains safe with CHES Foundation.
For the first 20 attendees registering that have vWD, one $25 Amazon gift card will be provided per household to the email address used for registration, provided the participant remains on camera during the session.